R. Agra

发表

Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

J. González-Juanatey, C. Almenglo, M. Couselo-Seijas, 2021, Journal of Molecular Medicine.

Variations in Platelet Proteins Associated With ST-Elevation Myocardial Infarction: Novel Clues on Pathways Underlying Platelet Activation in Acute Coronary Syndromes

Ángel García, J. González-Juanatey, L. Grigorian-Shamagian, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Clinical and Population Studies Variations in Platelet Proteins Associated With ST-Elevation Myocardial Infarction Novel Clues on Pathways Underlying Platelet Activation in Acute Coronary Syndromes

L. Grigorian-Shamagian, J. Alonso, R. Agra, 2011 .

Omentin treatment of epicardial fat improves its anti‐inflammatory activity and paracrine benefit on smooth muscle cells

Á. Fernández-Trasancos, Á. L. Fernández, J. González-Juanatey, 2017, Obesity.

Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact in de novo heart failure patients

Á. Fernández-Trasancos, Á. L. Fernández, J. González-Juanatey, 2018, International journal of medical sciences.

Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability

Á. L. Fernández, J. González-Juanatey, R. Agra, 2018, Cardiovascular research.

Research update for articles published in EJCI in 2014

W. März, T. Miazgowski, G. Niccoli, 2016, European journal of clinical investigation.

Differential Association of S100A9, an Inflammatory Marker, and p53, a Cell Cycle Marker, Expression with Epicardial Adipocyte Size in Patients with Cardiovascular Disease

Á. Fernández-Trasancos, J. González-Juanatey, R. Agra, 2014, Inflammation.

Impaired Adipogenesis and Insulin Resistance in Epicardial Fat‐Mesenchymal Cells From Patients With Cardiovascular Disease

Á. Fernández-Trasancos, Á. L. Fernández, J. González-Juanatey, 2014, Journal of cellular physiology.

The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.

J. González-Juanatey, R. Agra, J. García-Acuña, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Obesity-Related Genetic Determinants of Heart Failure Prognosis

M. Calaza, Á. Fernández-Trasancos, M. Gago-Domínguez, 2019, Cardiovascular Drugs and Therapy.

Differential Association of S100A9, an Inflammatory Marker, and p53, a Cell Cycle Marker, Expression with Epicardial Adipocyte Size in Patients with Cardiovascular Disease

Á. Fernández-Trasancos, J. González-Juanatey, R. Agra, 2014, Inflammation.

Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study

Ángel García, J. González-Juanatey, J. Alonso, 2010, PloS one.

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition

F. Casanueva, M. Carreira, Á. Fernández-Trasancos, 2017, Cardiovascular Diabetology.

Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure.

F. Casanueva, M. Carreira, Á. Fernández-Trasancos, 2017, International journal of cardiology.

Correction: Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study

Ángel García, J. González-Juanatey, J. Alonso, 2011, PLoS ONE.

Differential behavior between S100A9 and adiponectin in coronary artery disease. Plasma or epicardial fat.

Á. Fernández-Trasancos, J. González-Juanatey, D. Pascual-Figal, 2014, Life sciences.

Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients

Á. Fernández-Trasancos, J. González-Juanatey, D. Pascual-Figal, 2014, European journal of clinical investigation.